Purpose: To systematically study somatic variants arising during development in the human brain across a spectrum of neurodegenerative disorders. Methods: In this study we developed a pipeline to identify somatic variants from exome sequencing data in 1461 diseased and control human brains. Eighty-eight percent of the DNA samples were extracted from the cerebellum. Identified somatic variants were validated by targeted amplicon sequencing and/or PyroMark® Q24. Results: We observed somatic coding variants present in >10% of sampled cells in at least 1% of brains. The mutational signature of the detected variants showed a predominance of C>T variants most consistent with arising from DNA mismatch repair, occurred frequently in genes that are highly expressed within the central nervous system, and with a minimum somatic mutation rate of 4.25 × 10 −10 per base pair per individual. Conclusion: These findings provide proof-of-principle that deleterious somatic variants can affect sizeable brain regions in at least 1% of the population, and thus have the potential to contribute to the pathogenesis of common neurodegenerative diseases.
CITATION STYLE
Wei, W., Keogh, M. J., Aryaman, J., Golder, Z., Kullar, P. J., Wilson, I., … Chinnery, P. F. (2019). Frequency and signature of somatic variants in 1461 human brain exomes. Genetics in Medicine, 21(4), 904–912. https://doi.org/10.1038/s41436-018-0274-3
Mendeley helps you to discover research relevant for your work.